Literature DB >> 26166430

Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.

Chelsea A Snyder1, Michael L Goodson2, Amy C Schroeder3, Martin L Privalsky4.   

Abstract

Alternative mRNA splicing diversifies the products encoded by the NCoR and SMRT corepressor loci. There is a programmed alteration in NCoR mRNA splicing during adipocyte differentiation from an NCoRω isoform, which contains three nuclear receptor interaction domains, to an NCoRδ isoform that contains two nuclear receptor interaction domains. This alternative mRNA splicing of NCoR has profound effects on adiposity and on diabetes in mouse models. We report here that dexamethasone, a powerful regulator of metabolism and of adipocyte differentiation, confers this change in NCoR mRNA splicing in cultured adipocytes. We also demonstrate that changes in dietary components can consistently, if moderately, modulate the total transcript levels and the mRNA splicing of NCoR and SMRT in both cultured cells and intact mice. This ability of alternative corepressor mRNA splicing to respond to nutritional changes confirms its importance in regulating glucose and lipid metabolism, and its promise as a therapeutic candidate for metabolic disorders such as type 2 diabetes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alternative mRNA splicing; Corepressors; Isoforms; NCoR; SMRT; Transcriptional regulation

Mesh:

Substances:

Year:  2015        PMID: 26166430      PMCID: PMC4556269          DOI: 10.1016/j.mce.2015.06.036

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  44 in total

1.  Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Authors:  Michael L Goodson; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 2.  Transcriptional coregulators in the control of energy homeostasis.

Authors:  Jérôme N Feige; Johan Auwerx
Journal:  Trends Cell Biol       Date:  2007-05-01       Impact factor: 20.808

3.  The adipogenic transcriptional cofactor ZNF638 interacts with splicing regulators and influences alternative splicing.

Authors:  Chen Du; Xinran Ma; Sunitha Meruvu; Lynne Hugendubler; Elisabetta Mueller
Journal:  J Lipid Res       Date:  2014-07-14       Impact factor: 5.922

4.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids.

Authors:  Z Wu; N L Bucher; S R Farmer
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

5.  The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.

Authors:  Christine Yu; Kathleen Markan; Karla A Temple; Dianne Deplewski; Matthew J Brady; Ronald N Cohen
Journal:  J Biol Chem       Date:  2005-02-03       Impact factor: 5.157

Review 6.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

7.  NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids.

Authors:  Pingping Li; Nathanael J Spann; Minna U Kaikkonen; Min Lu; Da Young Oh; Jesse N Fox; Gautam Bandyopadhyay; Saswata Talukdar; Jianfeng Xu; William S Lagakos; David Patsouris; Aaron Armando; Oswald Quehenberger; Edward A Dennis; Steven M Watkins; Johan Auwerx; Christopher K Glass; Jerrold M Olefsky
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

8.  Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  J Thyroid Res       Date:  2011-06-08

9.  Nuclear receptor corepressors and PPARgamma.

Authors:  Ronald N Cohen
Journal:  Nucl Recept Signal       Date:  2006-02-08

10.  New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR.

Authors:  Kristopher J Stanya; Hung-Ying Kao
Journal:  Cell Div       Date:  2009-04-21       Impact factor: 5.130

View more
  7 in total

Review 1.  New insights into thyroid hormone action.

Authors:  Arturo Mendoza; Anthony N Hollenberg
Journal:  Pharmacol Ther       Date:  2017-02-04       Impact factor: 12.310

Review 2.  Gene-Specific Actions of Transcriptional Coregulators Facilitate Physiological Plasticity: Evidence for a Physiological Coregulator Code.

Authors:  Michael R Stallcup; Coralie Poulard
Journal:  Trends Biochem Sci       Date:  2020-03-13       Impact factor: 13.807

Review 3.  Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health.

Authors:  Yunqi Chao; Yonghui Jiang; Mianling Zhong; Kaiyan Wei; Chenxi Hu; Yifang Qin; Yiming Zuo; Lili Yang; Zheng Shen; Chaochun Zou
Journal:  Cell Biosci       Date:  2021-04-01       Impact factor: 7.133

Review 4.  Impacts of Alternative Splicing Events on the Differentiation of Adipocytes.

Authors:  Jung-Chun Lin
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

5.  Corepressor diversification by alternative mRNA splicing is species specific.

Authors:  Martin L Privalsky; Chelsea A Snyder; Michael L Goodson
Journal:  BMC Evol Biol       Date:  2016-10-19       Impact factor: 3.260

Review 6.  Alternative mRNA Splicing in the Pathogenesis of Obesity.

Authors:  Chi-Ming Wong; Lu Xu; Mabel Yin-Chun Yau
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

7.  Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.

Authors:  Michael L Goodson; Trina A Knotts; Elsie L Campbell; Chelsea A Snyder; Briana M Young; Martin L Privalsky
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.